10-K Filing

HealthLynked Corp CIK: 1680139 FY 2019

Filing Information

Form Type	10-K
Accession Number	`0001213900-20-007998`
Period End Date	20191231
Filing Date	20200330
Fiscal Year	2019
Fiscal Period	FY
XBRL Instance	hlyk-20191231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 78 Income Statement 42 Cash Flow Statement 105 Stockholders Equity 38

Balance Sheet 78 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, net of allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$13.97K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$13.97K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$749.32K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$752.17K	USD	Point-in-time
Goodwill and intangible assets, net of accumulated amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$5.91K	USD	Point-in-time
Goodwill and intangible assets, net of accumulated amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	-	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$50.01K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$110.44K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$135.78K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $13,972 and $13,972 as of December 31, 2019 and 2018, respectively	`AccountsReceivableNetCurrent`	$114.88K	USD	Point-in-time
Convertible notes payable, net of original issue discount and debt discount	`DebtInstrumentUnamortizedDiscountCurrent`	$777.67K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $13,972 and $13,972 as of December 31, 2019 and 2018, respectively	`AccountsReceivableNetCurrent`	$83.25K	USD	Point-in-time
Convertible notes payable, net of original issue discount and debt discount	`DebtInstrumentUnamortizedDiscountCurrent`	$386.47K	USD	Point-in-time
Inventory	`InventoryNet`	$70.46K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventory	`InventoryNet`	-	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$28.54K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$119.33K	USD	Point-in-time
Deferred offering costs	`DeferredOfferingCosts`	$19.20K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	85.18M	shares	Point-in-time
Deferred offering costs	`DeferredOfferingCosts`	$96.02K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	109.89M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	109.89M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$375.23K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$402.68K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	85.18M	shares	Point-in-time
Common stock issuable, par value	`CommonStockIssuableIssuePrice`	$0.00	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation of $749,316 and $752,173 as of December 31, 2019 and 2018, respectively	`PropertyPlantAndEquipmentNet`	$513.79K	USD	Point-in-time
Common stock issuable, par value	`CommonStockIssuableIssuePrice`	$0.00	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation of $749,316 and $752,173 as of December 31, 2019 and 2018, respectively	`PropertyPlantAndEquipmentNet`	$42.60K	USD	Point-in-time
Common stock issuable, shares	`CommonStockIssuableShares`	1.05M	shares	Point-in-time
Goodwill and intangible assets, net of accumulated amortization of $5,908 and $0 as of December 31, 2019 and 2018, respectively	`IntangibleAssetsNetIncludingGoodwill`	-	USD	Point-in-time
Common stock issuable, shares	`CommonStockIssuableShares`	114,080.00	shares	Point-in-time
Goodwill and intangible assets, net of accumulated amortization of $5,908 and $0 as of December 31, 2019 and 2018, respectively	`IntangibleAssetsNetIncludingGoodwill`	$1.34M	USD	Point-in-time
ROU lease assets and deposits	`LeaseAssetsNonCurrent`	$9.54K	USD	Point-in-time
ROU lease assets and deposits	`LeaseAssetsNonCurrent`	$293.12K	USD	Point-in-time
Total Assets	`Assets`	$427.36K	USD	Point-in-time
Total Assets	`Assets`	$2.55M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$394.33K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$836.47K	USD	Point-in-time
Capital lease, current portion	`CapitalLeaseObligationsCurrent`	$19.88K	USD	Point-in-time
Capital lease, current portion	`CapitalLeaseObligationsCurrent`	-	USD	Point-in-time
Lease liability, current portion	`OperatingLeaseLiabilityCurrent`	-	USD	Point-in-time
Lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$201.52K	USD	Point-in-time
Due to related party, current portion	`DueToRelatedPartiesCurrent`	$493.46K	USD	Point-in-time
Due to related party, current portion	`DueToRelatedPartiesCurrent`	$429.72K	USD	Point-in-time
Notes payable to related party, current portion	`NotesPayableRelatedPartiesClassifiedCurrent`	$672.47K	USD	Point-in-time
Notes payable to related party, current portion	`NotesPayableRelatedPartiesClassifiedCurrent`	$743.96K	USD	Point-in-time
Convertible notes payable, net of original issue discount and debt discount of $777,668 and $386,473 as of December 31, 2019 and 2018, respectively	`ConvertibleDebtCurrent`	$1.04M	USD	Point-in-time
Convertible notes payable, net of original issue discount and debt discount of $777,668 and $386,473 as of December 31, 2019 and 2018, respectively	`ConvertibleDebtCurrent`	$1.54M	USD	Point-in-time
Contingent acquisition consideration	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$500.00K	USD	Point-in-time
Contingent acquisition consideration	`BusinessCombinationContingentConsiderationLiabilityCurrent`	-	USD	Point-in-time
Derivative financial instruments	`DerivativeInstrumentsAndHedgesLiabilities`	$800.44K	USD	Point-in-time
Derivative financial instruments	`DerivativeInstrumentsAndHedgesLiabilities`	$991.29K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$3.36M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$5.31M	USD	Point-in-time
Capital leases, long-term portion	`CapitalLeaseObligationsNoncurrent`	-	USD	Point-in-time
Capital leases, long-term portion	`CapitalLeaseObligationsNoncurrent`	$3.06K	USD	Point-in-time
Lease liability, long term portion	`OperatingLeaseLiabilityNoncurrent`	$80.51K	USD	Point-in-time
Lease liability, long term portion	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Total Liabilities	`Liabilities`	$5.39M	USD	Point-in-time
Total Liabilities	`Liabilities`	$3.36M	USD	Point-in-time
Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 109,894,490 and 85,178,902 shares issued and outstanding as of December 31, 2019 and 2018, respectively	`CommonStockValue`	$8.52K	USD	Point-in-time
Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 109,894,490 and 85,178,902 shares issued and outstanding as of December 31, 2019 and 2018, respectively	`CommonStockValue`	$10.99K	USD	Point-in-time
Common stock issuable, $0.0001 par value; 1,047,904 and 114,080 shares as of December 31, 2019 and 2018, respectively	`CommonStockIssuableValue`	$159.54K	USD	Point-in-time
Common stock issuable, $0.0001 par value; 1,047,904 and 114,080 shares as of December 31, 2019 and 2018, respectively	`CommonStockIssuableValue`	$26.14K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$7.53M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$13.02M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-10.50M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-16.03M	USD	Point-in-time
Total Shareholders' Deficit	`StockholdersEquity`	$-2.05M	USD	Point-in-time
Total Shareholders' Deficit	`StockholdersEquity`	$-2.84M	USD	Point-in-time
Total Shareholders' Deficit	`StockholdersEquity`	$-2.93M	USD	Point-in-time
Total Liabilities and Shareholders' Deficit	`LiabilitiesAndStockholdersEquity`	$2.55M	USD	Point-in-time
Total Liabilities and Shareholders' Deficit	`LiabilitiesAndStockholdersEquity`	$427.36K	USD	Point-in-time

Income Statement 42 line items

Line Item	Tag	Value	Unit	Period
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$2.26M	USD	Annual
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$4.02M	USD	Annual
Practice salaries and benefits	`LaborAndRelatedExpense`	$2.39M	USD	Annual
Practice salaries and benefits	`LaborAndRelatedExpense`	$1.45M	USD	Annual
Other practice operating costs	`OperatingCostsAndExpenses`	$916.41K	USD	Annual
Other practice operating costs	`OperatingCostsAndExpenses`	$1.85M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$2.92M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$2.84M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$73.39K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$23.78K	USD	Annual
Total Operating Expenses	`OperatingExpenses`	$7.23M	USD	Annual
Total Operating Expenses	`OperatingExpenses`	$5.23M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-2.97M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-3.21M	USD	Annual
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.23M	USD	Annual
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-393.12K	USD	Annual
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	$-121.51K	USD	Annual
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	$-140.79K	USD	Annual
Financing cost	`AmortizationOfFinancingCosts`	$135.53K	USD	Annual
Financing cost	`AmortizationOfFinancingCosts`	$1.22M	USD	Annual
Amortization of original issue and debt discounts on notes payable and convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-763.62K	USD	Annual
Amortization of original issue and debt discounts on notes payable and convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-1.26M	USD	Annual
Change in fair value of derivative financial instrument	`GainLossOnDerivativeInstrumentsNetPretax`	$671.82K	USD	Annual
Change in fair value of derivative financial instrument	`GainLossOnDerivativeInstrumentsNetPretax`	$-106.14K	USD	Annual
Interest expense	`InterestExpense`	$193.11K	USD	Annual
Interest expense	`InterestExpense`	$244.09K	USD	Annual
Total other expenses	`NonoperatingIncomeExpense`	$-2.32M	USD	Annual
Total other expenses	`NonoperatingIncomeExpense`	$-2.82M	USD	Annual
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-5.53M	USD	Annual
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-5.79M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Net loss	`NetIncomeLoss`	$-5.79M	USD	Annual
Net loss	`NetIncomeLoss`	$-5.53M	USD	Annual
Basic	`EarningsPerShareBasic`	$-0.07	USD	Annual
Basic	`EarningsPerShareBasic`	$-0.06	USD	Annual
Fully diluted	`EarningsPerShareDiluted`	$-0.07	USD	Annual
Fully diluted	`EarningsPerShareDiluted`	$-0.06	USD	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	99.06M	shares	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	78.82M	shares	Annual
Fully diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	78.82M	shares	Annual
Fully diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	99.06M	shares	Annual

Cash Flow Statement 105 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-5.79M	USD	Annual
Net loss	`NetIncomeLoss`	$-5.53M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$73.39K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$23.78K	USD	Annual
Stock based compensation, including amortization of prepaid fees	`EmployeeBenefitsAndShareBasedCompensation`	$474.23K	USD	Annual
Stock based compensation, including amortization of prepaid fees	`EmployeeBenefitsAndShareBasedCompensation`	$519.93K	USD	Annual
Amortization of original issue discount and debt discount on convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-763.62K	USD	Annual
Amortization of original issue discount and debt discount on convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-1.26M	USD	Annual
Financing cost	`AmortizationOfFinancingCosts`	$135.53K	USD	Annual
Financing cost	`AmortizationOfFinancingCosts`	$1.22M	USD	Annual
Change in fair value of derivative financial instruments	`ChangeInFairValueOfDerivativeFinancialInstrument`	$671.82K	USD	Annual
Change in fair value of derivative financial instruments	`ChangeInFairValueOfDerivativeFinancialInstrument`	$-106.14K	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.23M	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-393.12K	USD	Annual
Change in fair value of debt	`NoncashExpense`	$140.79K	USD	Annual
Change in fair value of debt	`NoncashExpense`	$121.51K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.53K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-31.63K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	-	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$-1.65K	USD	Annual
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-53.35K	USD	Annual
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$96.70K	USD	Annual
ROU lease assets	`IncreaseDecreaseInRightOfUseLeaseAssets`	$282.37K	USD	Annual
ROU lease assets	`IncreaseDecreaseInRightOfUseLeaseAssets`	-	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$492.21K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$193.40K	USD	Annual
Lease liability	`IncreaseDecreaseInLeaseLiability`	$278.02K	USD	Annual
Lease liability	`IncreaseDecreaseInLeaseLiability`	-	USD	Annual
Due to related party, current portion	`IncreaseDecreaseInDueToRelatedPartiesCurrent`	$65.84K	USD	Annual
Due to related party, current portion	`IncreaseDecreaseInDueToRelatedPartiesCurrent`	$63.77K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.36M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.36M	USD	Annual
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$10.06K	USD	Annual
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.00K	USD	Annual
Acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	Annual
Acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$465.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-475.06K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-3.00K	USD	Annual
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.66M	USD	Annual
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$2.63M	USD	Annual
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	Annual
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$275.00	USD	Annual
Proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	$1.26M	USD	Annual
Proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	$2.17M	USD	Annual
Repayment of convertible notes	`RepaymentsOfConvertibleDebt`	$1.02M	USD	Annual
Repayment of convertible notes	`RepaymentsOfConvertibleDebt`	$1.39M	USD	Annual
Proceeds from related party loans	`ProceedsFromRelatedPartyDebt`	$101.45K	USD	Annual
Proceeds from related party loans	`ProceedsFromRelatedPartyDebt`	-	USD	Annual
Repayment of related party loans	`RepaymentsOfRelatedPartyDebt`	-	USD	Annual
Repayment of related party loans	`RepaymentsOfRelatedPartyDebt`	$9.00K	USD	Annual
Proceeds from notes payable and bank loans	`ProceedsFromBankDebt`	-	USD	Annual
Proceeds from notes payable and bank loans	`ProceedsFromBankDebt`	$73.50K	USD	Annual
Repayment of notes payable and bank loans	`RepaymentsOfBankDebt`	$165.88K	USD	3 Qtrs
Repayment of notes payable and bank loans	`RepaymentsOfBankDebt`	$199.07K	USD	Annual
Repayment of notes payable and bank loans	`RepaymentsOfBankDebt`	-	USD	Annual
Payments on capital leases	`RepaymentsOfDebtAndCapitalLeaseObligations`	$16.82K	USD	Annual
Payments on capital leases	`RepaymentsOfDebtAndCapitalLeaseObligations`	-	USD	Annual
Repurchase and retirement of treasury stock	`TreasuryStockReissuedAtLowerThanRepurchasePrice`	$-1.20K	USD	Annual
Repurchase and retirement of treasury stock	`TreasuryStockReissuedAtLowerThanRepurchasePrice`	$-5.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.44M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.81M	USD	Annual
Net (decrease) increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-25.34K	USD	Annual
Net (decrease) increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$85.77K	USD	Annual
Cash, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$50.01K	USD	Point-in-time
Cash, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$110.44K	USD	Point-in-time
Cash, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$135.78K	USD	Point-in-time
Cash, end of period	`CashAndCashEquivalentsAtCarryingValue`	$50.01K	USD	Point-in-time
Cash, end of period	`CashAndCashEquivalentsAtCarryingValue`	$110.44K	USD	Point-in-time
Cash, end of period	`CashAndCashEquivalentsAtCarryingValue`	$135.78K	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	$38.13K	USD	Annual
Cash paid during the period for interest	`InterestPaidNet`	$79.84K	USD	Annual
Cash paid during the period for income tax	`IncomeTaxesPaid`	-	USD	Annual
Cash paid during the period for income tax	`IncomeTaxesPaid`	-	USD	Annual
Initial derivative liability and fair value of beneficial conversion feature and original issue discount allocated to proceeds of variable convertible notes payable	`FairValueOfWarrantsBeneficialConversionFeatureAndOriginalIssueDiscount`	$1.85M	USD	Annual
Initial derivative liability and fair value of beneficial conversion feature and original issue discount allocated to proceeds of variable convertible notes payable	`FairValueOfWarrantsBeneficialConversionFeatureAndOriginalIssueDiscount`	$1.87M	USD	Annual
Common stock issuable issued during period	`CommonStockToBeIssuedNowIssued`	$35.00	USD	Annual
Common stock issuable issued during period	`CommonStockToBeIssuedNowIssued`	$13.80K	USD	Annual
Fair value of warrants issued for professional service	`FairValueAdjustmentOfWarrants`	$130.31K	USD	Annual
Fair value of warrants issued for professional service	`FairValueAdjustmentOfWarrants`	$54.26K	USD	Annual
Conversion of convertible note payable to common shares	`ConversionOfConvertibleNotesPayableToCommonStock`	$62.04K	USD	Annual
Conversion of convertible note payable to common shares	`ConversionOfConvertibleNotesPayableToCommonStock`	$1.22M	USD	Annual
Fair value of common shares issued with convertible notes payable	`Fairvalueofcommonsharesissuedwithconvertiblenotespayable`	$5.59K	USD	Annual
Fair value of common shares issued with convertible notes payable	`Fairvalueofcommonsharesissuedwithconvertiblenotespayable`	$28.32K	USD	Annual
Cashless exercise of options and warrants	`Cashlessexerciseofwarrants`	$200.00	USD	Annual
Cashless exercise of options and warrants	`Cashlessexerciseofwarrants`	$230.00	USD	Annual
Adoption of lease obligation and ROU asset	`AdoptionOfLeaseObligationAndROUAsset`	-	USD	Annual
Adoption of lease obligation and ROU asset	`AdoptionOfLeaseObligationAndROUAsset`	$560.05K	USD	Annual
Fair value of shares issued as acquisition consideration	`StockIssued1`	$1.00M	USD	Annual
Fair value of shares issued as acquisition consideration	`StockIssued1`	-	USD	Annual
Value of contingent acquisition consideration	`ContingentAcquisitionConsiderationValue`	$500.00K	USD	Annual
Value of contingent acquisition consideration	`ContingentAcquisitionConsiderationValue`	-	USD	Annual
Fair value of warrants issued and modifications of beneficial conversion feature to extend convertible notes payable	`FairValueOfWarrantsIssuedAndModificationsOfBeneficialConversionFeatureToExtendConvertibleNotesPayable`	$229.90K	USD	Annual
Fair value of warrants issued and modifications of beneficial conversion feature to extend convertible notes payable	`FairValueOfWarrantsIssuedAndModificationsOfBeneficialConversionFeatureToExtendConvertibleNotesPayable`	$703.27K	USD	Annual
Fair value of warrants issued to extend related party notes payable	`FairValueOfWarrantsIssuedPursuantToAmendedInvestmentAgreement`	$337.47K	USD	Annual
Fair value of warrants issued to extend related party notes payable	`FairValueOfWarrantsIssuedPursuantToAmendedInvestmentAgreement`	$274.80K	USD	Annual
Fair value of warrants issued to extinguish convertible notes payable	`FairValueOfWarrantsIssuedToExtinguishConvertibleNotesPayable`	$143.01K	USD	Annual
Fair value of warrants issued to extinguish convertible notes payable	`FairValueOfWarrantsIssuedToExtinguishConvertibleNotesPayable`	-	USD	Annual
Derivative liabilities written off with repayment of convertible notes payable	`DerivativeLiabilitiesWrittenOffWithRepaymentOfConvertibleNotesPayable`	$608.39K	USD	Annual
Derivative liabilities written off with repayment of convertible notes payable	`DerivativeLiabilitiesWrittenOffWithRepaymentOfConvertibleNotesPayable`	$1.10M	USD	Annual
Derivative liabilities written off at end of warrant repricing period	`Derivativeliabilitieswrittenoffatendofwarrantrepricingperiod`	-	USD	Annual
Derivative liabilities written off at end of warrant repricing period	`Derivativeliabilitieswrittenoffatendofwarrantrepricingperiod`	$2.78M	USD	Annual
Derivative liabilities reclassified into additional paid in capital for convertible notes payable conversion into shares	`DerivativesLiabilitiesAdditionalPaidInCapitalForConvertibleNotsPayableConversion`	$63.55K	USD	Annual
Derivative liabilities reclassified into additional paid in capital for convertible notes payable conversion into shares	`DerivativesLiabilitiesAdditionalPaidInCapitalForConvertibleNotsPayableConversion`	-	USD	Annual
Fair value of warrants allocated to proceeds of fixed convertible notes payable	`FairValueOfWarrantsAllocatedToProceedsOfFixedConvertibleNotesPayable`	-	USD	Annual
Fair value of warrants allocated to proceeds of fixed convertible notes payable	`FairValueOfWarrantsAllocatedToProceedsOfFixedConvertibleNotesPayable`	$225.32K	USD	Annual

Stockholders Equity 38 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$-2.05M	USD	Point-in-time
Balance	`StockholdersEquity`	$-2.84M	USD	Point-in-time
Balance	`StockholdersEquity`	$-2.93M	USD	Point-in-time
Acquisition of Hughes Center for Functional Medicine	`StockIssuedDuringPeriodValueAcquisitions`	$1.00M	USD	Annual
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$1.50M	USD	Annual
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$2.45M	USD	Annual
Fair value of warrants allocated to proceeds of common stock	`AdjustmentsToAdditionalPaindInCapitalCommonStock`	$154.65K	USD	Annual
Fair value of warrants allocated to proceeds of common stock	`AdjustmentsToAdditionalPaindInCapitalCommonStock`	$181.79K	USD	Annual
Shares issued with convertible notes payable	`Sharesissuedwithconvertiblenotespayable`	$28.32K	USD	Annual
Fair value of shares issued with convertible notes payable	`FairValueOfSharesIssuedWithConvertibleNotesPayable`	$5.60K	USD	Annual
Fair value of warrants issued to extend convertible notes payable	`FairValueOfWarrantsIssuedToExtendConvertibleNotesPayable`	$229.90K	USD	Annual
Fair value of warrants allocated to proceeds of convertible notes payable	`FairValueOfWarrantsAllocatedToProceedsOfConvertibleNotesPayable`	$225.32K	USD	Annual
Fair value of warrants issued to retire convertible notes payable	`AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedToRetireConvertibleNotesPayable`	$143.01K	USD	Annual
Fair value of warrants issued and modifications of beneficial conversion feature to extend convertible notes payable	`FairValueOfWarrantsIssuedAndModificationsOfBeneficialConversionsFeature`	$1.05M	USD	Annual
Conversion of convertible notes payable to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$42.21K	USD	Annual
Conversion of convertible notes payable to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$1.22M	USD	Annual
Conversion of convertible notes payable to common stock, shares	`StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities`	133,333.00	shares	Point-in-time
Conversion of convertible notes payable to common stock, shares	`StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities`	175,000.00	shares	Point-in-time
Conversion of convertible notes payable to common stock, shares	`StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities`	25,000.00	shares	Point-in-time
Derivative liabilities transferred to additional paid-in capital	`AdjustmentsToAdditionalPaidInCapitalDerivativeLiabilitiesTransferred`	$2.85M	USD	Annual
Fair value of warrants issued for professional services	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$54.26K	USD	Annual
Fair value of warrants issued for professional services	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$296.45K	USD	Annual
Consultant fees payable with common shares and warrants	`StockToBeIssuedForConsultantFees`	$49.56K	USD	Annual
Consultant fees payable with common shares and warrants	`StockToBeIssuedForConsultantFees`	$175.32K	USD	Annual
Fair value of warrants issued to extend related party notes payable	`FairValueOfWarrantsIssuedToExtendRelatedPartyNotesPayable`	$337.47K	USD	Annual
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$102.63K	USD	Annual
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$213.53K	USD	Annual
Sale of common stock initially allocated to derivative financial instruments	`AdjustmentsToAdditionalPaidInCapitalValueSaleOfCommonStockDerivativeFinancialInstruments`	$-1.77M	USD	Annual
Exercise of stock options	`ExerciseOfStockOptionsValue`	-	USD	Annual
Exercise of stock warrants	`Exerciseofwarrants`	$275.00	USD	Annual
Exercise of stock warrants	`Exerciseofwarrants`	-	USD	Annual
Repurchase and retirement of treasury shares	`RepurchaseAndRetirementOfTreasuryShares`	$-5.00K	USD	Annual
Repurchase of treasury stock	`RepurchaseOfTreasuryStock`	$-1.20K	USD	Annual
Net loss	`ProfitLoss`	$-5.79M	USD	Annual
Net loss	`ProfitLoss`	$-5.53M	USD	Annual
Balance	`StockholdersEquity`	$-2.05M	USD	Point-in-time
Balance	`StockholdersEquity`	$-2.84M	USD	Point-in-time
Balance	`StockholdersEquity`	$-2.93M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.